Loading…
Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage
Highlights • We conducted a meningococcal carriage study among children aged 1–7 years old. • We evaluated the impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the pharyngeal meningococcal carriage. • MenBvac reduces meningococcal carriage and may hence confer herd immunity. • The nove...
Saved in:
Published in: | Vaccine 2013-09, Vol.31 (40), p.4416-4420 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Highlights • We conducted a meningococcal carriage study among children aged 1–7 years old. • We evaluated the impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the pharyngeal meningococcal carriage. • MenBvac reduces meningococcal carriage and may hence confer herd immunity. • The novel meningococcal B vaccine that includes an OMV component may have an impact on carriage. |
---|---|
ISSN: | 0264-410X 1873-2518 0264-410X |
DOI: | 10.1016/j.vaccine.2013.06.080 |